The forecast is based on the fact that the Acceptance conditions remain unchanged, as the beginning of March, Merck had been presented. At that time, had told Moody’s, the ratings on Merck Millipore and stopped before completion of the transaction under scrutiny.
With the acquisition, Merck Millipore strengthen its division for "Life Science Chemicals division, which the group more balanced business profile to reach, Moody’s announced on. His Transactions add the group around 1.2 billion EUR and a Specialty product offerings. In addition, the division taking a solid position in the U.S., a market and improve its geographic spread.
Website: www.merck.de DJG / ebb / cbr
(END) Dow Jones Newswires
March 29, 2010 09:31 ET (13:31 GMT)